Volume 135; Issue 18

Main
Blood
Volume 135; Issue 18

Blood

Volume 135; Issue 18

1

Circulating angioimmunoblastic T-cell lymphoma cells

Liapis, Konstantinos, Paterakis, Georgios

Journal:

Année:

2020

Fichier:

PDF, 762 KB

2020

2

AL patients donât dare go without dara

Dispenzieri, Angela

Journal:

Année:

2020

Fichier:

PDF, 576 KB

2020

3

Disease and mutation: correlations coming to fruition

Schindler, Detlev, Kalb, Reinhard

Journal:

Année:

2020

Fichier:

PDF, 596 KB

2020

4

Home and away: clonal hematopoiesis in sibling transplants

Fabre, Margarete A., Vassiliou, George S.

Journal:

Année:

2020

Fichier:

PDF, 583 KB

2020

5

Clonal hematopoiesis in donors and long-term survivors of related allogeneic hematopoietic stem cell transplantation

Boettcher, Steffen, Wilk, C. Matthias, Singer, Jochen, Beier, Fabian, Burcklen, Elodie, Beisel, Christian, Ventura Ferreira, Monica S., Gourri, Elise, Gassner, Christoph, Frey, Beat M., Schanz, Urs, S

Journal:

Année:

2020

Fichier:

PDF, 1.47 MB

2020

6

Prognostic impact of CSF3R mutations in favorable risk childhood acute myeloid leukemia

Tarlock, Katherine, Alonzo, Todd, Wang, Yi-Cheng, Gerbing, Robert B., Ries, Rhonda E., Hylkema, Tiffany, Smith, Jenny L., Maxson, Julia E., Meshinchi, Soheil

Journal:

Année:

2020

Fichier:

PDF, 793 KB

2020

7

Safety, tolerability, and response rates of daratumumab in relapsed AL amyloidosis: results of a phase 2 study

Sanchorawala, Vaishali, Sarosiek, Shayna, Schulman, Amanda, Mistark, Meredith, Migre, Mary Ellen, Cruz, Ramon, Sloan, J. Mark, Brauneis, Dina, Shelton, Anthony C.

Journal:

Année:

2020

Fichier:

PDF, 830 KB

2020

8

Selective inhibition of Ph-positive ALL cell growth through kinase-dependent and -independent effects by CDK6-specific PROTACs

De Dominici, Marco, Porazzi, Patrizia, Xiao, Youcai, Chao, Allen, Tang, Hsin-Yao, Kumar, Gaurav, Fortina, Paolo, Spinelli, Orietta, Rambaldi, Alessandro, Peterson, Luke F., Petruk, Svetlana, Barletta,

Journal:

Année:

2020

Fichier:

PDF, 2.11 MB

2020

9

A prospective phase 2 trial of daratumumab in patients with previously treated systemic light-chain amyloidosis

Roussel, Murielle, Merlini, Giampaolo, Chevret, Sylvie, Arnulf, Bertrand, Stoppa, Anne Marie, Perrot, Aurore, Palladini, Giovanni, Karlin, Lionel, Royer, Bruno, Huart, Antoine, Macro, Margaret, Morel,

Journal:

Année:

2020

Fichier:

PDF, 991 KB

2020

10

CDK6 degradation hits Ph+ ALL hard

Hantschel, Oliver

Journal:

Année:

2020

Fichier:

PDF, 639 KB

2020

11

Interplay between the tyrosine kinases Chk and Csk and phosphatase PTPRJ is critical for regulating platelets in mice

Nagy, Zoltan, Mori, Jun, Ivanova, Vanesa-Sindi, Mazharian, Alexandra, Senis, Yotis A.

Journal:

Année:

2020

Fichier:

PDF, 2.39 MB

2020

12

Daratumumab for systemic AL amyloidosis: prognostic factors and adverse outcome with nephrotic-range albuminuria

Kimmich, Christoph R., Terzer, Tobias, Benner, Axel, Dittrich, Tobias, Veelken, Kaya, Carpinteiro, Alexander, Hansen, Timon, Goldschmidt, Hartmut, Seckinger, Anja, Hose, Dirk, Jauch, Anna, WÃ¶rner, St

Journal:

Année:

2020

Fichier:

PDF, 1.24 MB

2020

13

Association of clinical severity with FANCB variant type in Fanconi anemia

Jung, Moonjung, Ramanagoudr-Bhojappa, Ramanagouda, van Twest, Sylvie, Rosti, Rasim Ozgur, Murphy, Vincent, Tan, Winnie, Donovan, Frank X., Lach, Francis P., Kimble, Danielle C., Jiang, Caroline S., Va

Journal:

Année:

2020

Fichier:

PDF, 1.87 MB

2020